Current regulations (1998) on diagnosis and staging of lung cancer;Normativa actualizada (1998) sobre diagnóstico y estadifícación del carcinoma broncogénico

Archivos de Bronconeumologia

Volumn 34, Issue 9, 1998, Pages 437-452

  Rami Porta, R ^a   Duque Medina, J L ^b   Hernandez Hernandez J R ^c   Lopez Encuentra A ^d   Sanchez de Cos Escuin J ^e  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001574437     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30371-9     Document Type: Article

References (118)

1. López Encuentra A, León González C, López Mejías J et al. Grupo de Trabajo de SEPAR. Normativa sobre nomenclatura y clasificación del carcinoma broncogénico. Barcelona: Ediciones Doyma, S.A., 1986.
2. Nesbitt JC, Moores DWO. Staging of lung cáncer. En: Roth JA, Ruckdeschel JC, Eisenburger TH, editores. Thoracic oncology. Filadelfía: WB Saunders, 1995; 84-103.
3. Bearhs OH, Henson DE, Hutter RVP, Kennedy BJ, editores. American Joint Committee on Cáncer. Manual for staging of cáncer (4a ed.). Filadelfía: JB Lippincot Company, 1992; 115-122.
4. Hermanek P, Sobin LH, editores. Unión Internationale Contre le Cáncer. TNM classification of malignant tumours (4.a ed., 2.a revisión). Berlín: Springer-Verlag, 1992; 77-80.
5. Hermanek P, Henson DE, Hutter RVP, Sobin LH, editores. Unión Internationale Contre le Cáncer. TNM supplement 1993. A commentary on uniform use. Berlín: Springer-Verlag, 1993; 34-36.
6. Hermanek P, Henson DE, Hutter RVP, Sobin LH, editores. Unión Internationale Contre le Cáncer. TNM supplement 1993. A commentary on uniform use. Berlín: Springer-Verlag, 1993; 57.
7. Rami Porta R, Duque Medina JL, Hernández Hernández JR, López Encuentra A, Sánchez de Cos Escuín J. Grupo de Trabajo SEPAR. Normativa sobre diagnóstico y estadificación del carcinoma broncogénico. Barcelona: Ediciones Doyma, S.A., 1996.
8. Sobin LH, Wittekind Ch, editores. UICC International Unión Against Cáncer: TNM classification of malignant tumours (5a ed.). Nueva York: Wiley-Liss, 1997; 91-97.
9. Fleming ID, Cooper JS, Henson DE et al, editores. AJCC cáncer staging manual (5a ed.). Filadelfía: Lippincott-Raven, 1997; 127-137.
10. Mountain CF. Revisions in the international system for staging lung cáncer. Chest 1997; 111: 1.710-1.717.
11. Mountain CF, Dresler CM. Regional lymph node classification for lung cáncer staging. Chest 1997; 111: 1.718-1.723.
12. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind Ch, editores. International Unión Against Cáncer TNM Atlas (4a ed.). Berlín: Springer, 1997; 153-166.
13. American Thoracic Society/European Respiratory Society. Pretreatment evaluation of non-small-cell lung cáncer. Am J Respir Crit Care Med 1997; 156: 320-332.
14. Ginsberg R, Cox J, Green M et al. Staging classification committee. Lung Cáncer 197; 17 (Supi I): 11-13.
15. Rami-Porta R. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Analysis of survival according to the new 1997 stage grouping classification of lung cáncer. Lung Cáncer 1997; 18 (Supi I): 106-107.
16. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica (GCCB-SEPAR). Reflections on the revisions in the international system for staging lung cáncer. Chest 1998; 113: 1.728-1.729.
17. Goldstraw P. Report on the international workshop on intrathoracic staging. London, October 1996. Lung Cáncer 1997; 18: 107-111.
18. Carr DT, Holoye PY, Hong WK. Bronchogenic carcinoma. En: Murray JF, Nadel JA, editores. Textbook of respiratory medicine. Filadelfía: WB Saunders, 1994; 1.528-1.596.
19. Spiro SG. Lung tumours. En: Brewis RAL, Gibson GJ, Geddes DM, editores. Textbook of respiratory medicine. Londres: Bailliére Tindall, 1990; 832-879.
20. Garcés JM, Guasch Y, Planas J, Broquetas J, Drobnic L. Cáncer de pulmón. Análisis de 122 casos. Med Clin (Barc) 1982; 79: 441-444.
21. Karsell PR. Diagnostic tests for lung cáncer. Mayo Clin Proc 1993;68:288-296.
22. García Marrón M, Gallo Martín F, García Muñoz JP, Viejo Bañuelos JL. Estudio de las técnicas de diagnóstico en cien pacientes con carcinoma bronquial. Arch Bronconeumol 1986; 22: 17-23.
23. Lyubsky S, Jacobson MJ. Lung cáncer. Making the diagnosis. Chest 1991; 100:511-520.
24. Buccheri G, Barberis P, Delfíno MS. Diagnostic, morphologic and histopathologic correlates in bronchogenic carcinoma. A review of 1,045 bronchoscopic examinations. Chest 1991; 99: 809-814.
25. Romero Candeira S, Padilla Navas I, Jiménez Cruzado L, Pajes Juanola MA, Vilaplana Vilaplana E, Cabezas Jiménez A. Rentabilidad diagnóstica de la broncofibroscopia en el carcinoma bronquial. Rev Clin Esp 1984; 174: 243-246.
26. Grippi MA. Clinical aspects of lung cáncer. Semin Roentgenol 1990;25:12-24.
27. Popp W, Merkie M, Schreiber B, Rauscher H, Ritschka L, Zwick H. How much brushing is enough for the diagnosis of lung tumors. Cáncer 1992; 70: 2.278-2.280.
28. Popovich J, Kvale PA, Eichenhorn MS, Radke JR, Ohorodnik M, Fine G. Diagnostic accuracy of múltiple biopsies from flexible fiberoptic bronchoscopy. Am Rev Respir Dis 1982; 125: 521-523. 52.
29. Lee ChH, Wang ChH, Lin McH et al. Múltiple brushings with immediate Riu's stain via flexible fiberoptic bronchoscopy without fluoroscopic guidance in the diagnosis of peripheral pulmonary tumors. Thorax 1995; 50: 18-21.
30. De Gracia J, Bravo C, Miravitlles M et al. Diagnostic valué of bronchoalveolar lavage in peripheral lung cáncer. Am Rev RespirDis 1993; 147:649-652.
31. Pirozynsky M. Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cáncer. Chest 1992; 102: 372-374.
32. Marín Pérez A, Xaubet Mir A, Picado Valles C, Agustí Vidal A. Punción aspirativa transbronquial y lavado broncoalveolar en el diagnóstico del cáncer primitivo del pulmón. Arch Bronconeumol1989; 25:93-96.
33. Gasparini S, Ferretti M, Secchi EB, Baldelli S, Zucatosta L, Gusella P. Integration of transbronquial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or mases. Experience with 1,027 consecutive cases. Chest 1995; 108: 131-137.
34. Anders CT, Johnson JE, Bush BA, Matthews JI. Transbronchial biopsy without fluoroscopy. Chest 1988; 94: 557-560.
35. Zarbo RJ, Fenoglio-Preiser CM. Interinstitutional datábase for comparison of performance in lung fine-needle aspiration citology. A College of American Pathologists Q-Probe Study of 5,264 cases with histologic correlation. Arch Pathol Lab Med 1992; 116:463-470.
36. Salazar A, Westcott JL. The role of transthoracic needle biopsy for the diagnosis and staging of lung cáncer. Clin Chest Med 1993; 14:99-109.
37. Martínez Moragón E, Aparicio Urtasun J, Sanchís Aldas J et al. Fibrobroncoscopia en el cáncer de pulmón: relación entre radiología, endoscopia e histología, y rendimiento diagnóstico en una serie de 1.801 casos. Arch Bronconeumol 1994; 30: 291-296.
38. Castella J, Hernández Félix S, Puzo C et al. Punción bronquial aspirativa en las neoplasias localizadas en bronquios centrales. Arch Bronconeumol 1991; 27: 68-70.
39. Shure D. Transbronchial biopsy and needle aspiration. Chest 1989; 95: 1.130-1.138.
40. De Gregorio Ariza MA, Torre Nuez J, Alfonso Agurán ER, Duce García F, Villavieja Atance JL, Bustamante Arias E. Complicaciones y riesgos de la punción aspirativa transtorácica. Estudio en 873 pacientes y revisión de la literatura. Arch Bronconeumol 1990;26: 186-191.
41. Thomas JSJ, Lamb D, Ashcroft T et al. How reliable is the diagnosis of lung cáncer using small biopsy specimens? Report of a UKCCCR Lung Cáncer Working Party. Thorax 1993; 48: 1.135-1.139.
42. Kanters SDJM, Lammers JWJ, Voest EE. Molecular and biological factors in the prognosis of non-small cell lung cáncer. Eur Respir J 1995; 8: 1.389-1.397.
43. Johnson BE. Biologic and molecular prognostic factors. Impact on treatment of patients with non-small cell lung cáncer. Chest 1995; 107 (Supi): 287-290.
44. Smit EF, Groen HJM, Spiinter TAW, Ebeis T, Postmous PE. New prognostic factors in resectable non-small cell lung cáncer. Thorax 1996; 51: 638-646.
45. Ferrigno D, Buccheri G, Biggi A. Serum tumour markers in lung cáncer: history, biology and clinical applications. Eur Respir J 1994;7:186-197.
46. Hernández Hernández JR. Importancia y significado pronóstico de los marcadores tumorales en neumología. Arch Bronconeu mol 1997;33:485-487.
47. Rastel D, Ramaioli A, Comillie F, Thirion B. CYFRA 21-1, a sensitive and specifíc new tumour marker for squamous cell lung cáncer. Report of the First European Multicentre Evaluation. Eur J Cáncer 1994; 30A: 601-606.
48. Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakaji Ma S. Assessment of serum Cyfra 21-1 in lung cáncer. Cáncer 1996; 77: 1.274-1.277.
49. Buccheri G, Ferrigno D. Prognostic factors in lung cáncer: tables and comments. Eur Respir J 1994; 7: 1.350-1.364.
50. Ledermann JA. Serum neurone-specific enolase and other neuroendocrine markers in lung cáncer. Eur J Cáncer 1994; 30: 574-576.
51. Sánchez de Cos J, Masa F, Disdier C et al. Utilidad de la enolasa neuroespecífica sérica en el manejo clínico del carcinoma microcítico de pulmón. Arch Bronconeumol 1994; 30: 375-380.
52. Smart ChR. Annual screening using chest X-ray examination for the diagnosis of lung cáncer. Cáncer 1993; 72: 2.295-2.298.
53. Strauss GM. Measuring effectiveness of lung cáncer screening. Chest 1997; 112 (Supi): 216-228.
54. Mountain CF. A new international staging system for lung cáncer. Chest 1986; 89 (SupI): 224-233.
55. López Encuentra A. Clasificación anatómica del tumor y clasificación clínica del paciente. Decisiones individualizadas en situación clínica desfavorable. Ponencia "Abordaje multidisciplinario del tratamiento del carcinoma broncogénico". Lisboa: Primer Congreso Luso-Español de Neumología, 1989.
56. Nesbitt JC, Putnam JB, Waish GL, Roth JA, Mountain CF. Survival in eariy-stae non-small cell lung cáncer. Ann Thorac Surg 1995; 60: 466-472.
57. Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH. Prognostic factors in cáncer. Berlín: Springer-Verlag, 1995.
58. Mountain CF. Lung cáncer staging classification. Clin Chest Med 1993; 14:43-51.
59. Scaglioti GV. Symptoms and signs and staging of lung cáncer. Eur Respir Mon 1995; 1: 91-136.
60. Jaeschke R, Guyatt GH, Sackett DL. User's guides to the medical literature III. How to use an article about a diagnostic test A. Are the results ofthe study valid? JAMA 1994; 271: 389-391.
61. Jaeschke R, Guyatt GH, Sackett DL. User's guides to the medical literature III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994; 271: 703-707.
62. Société de Pneumologie de Langue Francaise. Bilan d'extension pré-thérapeutique du cáncer bronchique non á petites cellules. Rev Pneumol Clin 1992; 48: 35-50.
63. Goldstraw P, Rocmans P, Bael D et al. Pretreatment minimal staging for non-small cell lung cáncer: an updated consensus report. Lung Cáncer 1994; 11 (SupI 3): 1-4.
64. López Encuentra A, Linares Asensio MJ. Carcinoma broncogénico. En: Martín Escribano P, López Encuentra A, editores. Pautas de práctica clínica en neumología. Madrid: IDEPSA, 1996; 177-185.
65. Duran Cantolla J, Pagóla Hernández MA, Agüero Balbín R et al. Papel de la tomografía computarizada de tórax en la definición de la extensión anatómica en el carcinoma broncogénico. Arch Bronconeumol 1994; 30: 23-28.
66. White PG, Adams H, Crane MD, Butchart EG. Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours? Thorax 1994; 49: 951-957.
67. Hermán SJ, Winton TL, Weisbrod GL, Towers MJ, Mentzer SJ. Mediastinal invasión by bronchogenic carcinoma: CT signs. Radiology 1994; 190: 841-846.
68. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Valué of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cáncer. Eur J Cardiothorac Surg 1994; 8: 37-42.
69. Chin R, Ward R, Keyes JW et al. Mediastinal staging of nonsmall- cell lung cáncer with positrón emission tomography. Am J Respir Crit Care Med 1995; 152:2.090-2.096.
70. Sazón DAD, Santiago SM, Hoo GWS et al. Fluorodeoxyglucose- positron emission tomography in the detection and staging of lung cáncer. Am J Respir Crit Care Med 1996; 153: 417-421.
71. Salvatierra A, Baamonde C, Llamas JM, Cruz F, López Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990; 97: 1.052-1.058.
72. Michel F, Soler M, Imhof E, Peruchoud AP. Initial staging of non-small cell lung cáncer: valué of routine radioisotope bone scanning. Thorax 1991; 46: 469-473.
73. Márquez Pérez FL, Martínez Cruz R, López Encuentra A, Gómez Embuena A. Valor de los datos clínicos en la predicción de metástasis óseas estudiadas por rastreo óseo isotópico en el carcinoma broncogénico. Arch Bronconeumol 1993; 29: 320-323.
74. Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cáncer. Che.st 1994; 106: 1.025-1.029.
75. Colé FH, Thomas JE, Wilcox AB, Halford HH. Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile? Ann Thorac Surg 1994; 57: 838-840.
76. Colice GL, Birkmeyer JD, Black WC, Littenberg B, Silvestri GA. Cost-effectiveness of head CT in patients with lung cáncer without clinical evidence of metastases. Chest 1995; 108: 1.264- 1.271.
77. Silvestri GA, Lenz JE, Harper SN, Morse RA, Colice GL. The relationship of clinical findings to CT sean evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest 1992; 102: 1.748-1.751.
78. Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cáncer. Thorax 1994;49: 14-19.
79. Muers MF. Preoperative screening for metastases in lung cáncer. Thorax 1994; 49: 1-2.
80. Silvestri GA. Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cáncer: a meta-analysis. Ain J Respir Crit Care Med 1995; 152: 225-230.
81. Chauvin F, Trillet V, Court-Fortune I et al. Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decisión making. Chest 1992; 102: 497-502.
82. Richardson GE, Venzon DJ, Pheips R et al. Application of an algorithm for staging small-cell cáncer can save one third of the initial evaluation costs. Arch Intem Med 1993; 153: 329-337.
83. Bravo JL, Alix A, Manes N, García JM. Quimioterapia inductora y cirugía en el tratamiento del carcinoma broncogénico IIIA. En: Actualizaciones SEPAR. Barcelona: JR Prous, editores, 1995; 12:236-253.
84. Pujol JL, Daurés JP, Godard P, Michel FB. La chimiotherapie neó-adjuvante des cancers nogn á petites cellules des bronches localement avances. Rev Pneumol Clin 1994; 50: 147-154.
85. Ginsberg RJ. Neoadjuvant (induction) treatment for non-small cell lung cáncer. Lung Cáncer 1995; 12 (SupI 2): 33-40.
86. Martini N, Kris MG, Gralla RJ et al. The effects of preoperative chemoterapy on the resecability of non small cell lung carcinoma with mediastinal lymph node metastases. Ann Thorac Surg 1988; 45:370-379.
87. Ginsberg RJ. Multimodality therapy for stage III N2 lung cáncer. An overview. Chest 1993; 103 (SupI): 356-359.
88. Rosell R, Gómez-Codina J, Camps C et al. A randomized trial comparing preoperative chemoterapy plus surgery with surgery alone in patients with non small cell lung cáncer. N Engí J Med 1994;20:153-158.
89. Roth JA, Fosella F, Komaki R et al. A ranzomied trial comparing perioperative chemoterapy and surgery with surgery alone in resectable stage IIIA NSCLC. J Nati Cáncer Inst 1994; 86: 673-680.
90. Rusch VW, Albain KS, Crowley JJ et al and Southwest Oncology Group. Neoadjuvant therapy: a novel and effective treatment for stage IIIB non small cell lung cáncer. Ann Thorac Surg 1994;58:290-295.
91. Green MR, Ginsberg R, Ardizzoni A et al. Induction therapy for stage III NSCLC: a consensus report. Lung Cáncer 1994; 11 (SupI 3):9-10.
92. Raut Y, Huu N, Barra JA et al. Association chimiotherapie et chirurgie dans le tratement du carcinome bronchique épidermol'- de. Ann Chir: Chir Thorac Cardiovasc 1985; 39: 141-146.
93. Green M, Brodin O, Choi N et al. Pre-operative and post-operative treatments in stage III NSCLC. Lung Cáncer 1994; 10 (SupI I): 15-17.
94. Pujol JI, Parrat E, Lehmann M et al. Lung cáncer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation. Am J Respir Crit Care Med 1996; 153:243-249.
95. Ginsberg RJ. Surgical resection in neoadjuvant protocols. En: Lung Cáncer Study Group. Organisation et estructure.
96. Ginsberg RJ. Surgical considerations after preoperative treatment. Lung Cáncer 1994; 10 (SupII):213-217.
97. Myers JI, Askin FB, Yousem SA. Recommendations for the reporting of resected primary lung carcinomas. Hum Pathol 1995; 26:937-939.
98. Martini N, Flehinger BJ. The role of surgery in N2 lung cáncer. Surg Clin North Am 1987; 67: 1.037-1.049.
99. Libshitz HI, McKenna RJ, Mountain CF. Pattems of mediastinal metastases in bronchogenic carcinoma. Chest 1986; 91: 53-56.
100. Watanabe Y, Shimizu J, Tsubota M, Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cáncer. Chest 1990; 97: 1.059-1.065.
101. Ichinose Y, Yano T, Yocoyama H, Inoue T, Asoh H, Katsuda Y. The correlation between tumor size and lymphatic vessel invasión in resected peripheral stage I non small lung cáncer. A potential risk of limited resection. J Thorac Cardiovasc Surg 1994; 108:684-686.
102. Martini N. Surgical treatment of non-small cell lung cáncer by stage. Semin Surg Oncol 1990; 6: 248-254.
103. Naruke T, Goya T, Tsuchiya R et al. The importance of surgery to non-small cell carcinoma ofiung with mediastinal lymph node metástasis. Ann Thorac Surg 1988; 46: 603-610.
104. Schirren PF, Cuénoud H, Bülzebruck S et al. Chirurgie du carcinome bronchique avec envahissement nodulaire médiastinal. Ann Chir Thorac Cardiovasc 1994:48: 852-861.
105. Mountain CF. Expanded possibilities for surgical treatment of lung cáncer. Chest 1990; 97: 1.045-1.047.
106. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levéis of metástasis in resected lung cáncer. J Thorac Cardiovasc Surg 1978; 76: 832-839.
107. American Thoracic Society. Clinical staging primary lung cáncer. Am Rev Respir Dis 1983; 127: 1-6.
108. Grupo Cooperativo del Carcinoma Broncogénico-SEPAR. Hoja de recogida de datos inicial, 1995.
109. Naruke T. Mediastinal lymph node dissection. En: Shields TW, editor. General thoracic surgery (4.11 ed., Vol. 1). Baltimore: Wi- Iliams & Wiikins: 1994:469-480.
110. Goldstraw P. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cáncer. Thorax 1992; 47: 1-2.
111. Izbicki JR, Passiick B, Karg O et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cáncer. Ann Thorac Surg 1995; 59: 209-214.
112. Riquet M, Saab M. Techniques et indications chirurgicales dans le cáncer bronchique. En: Encycl Med Chir. Editions Techniques EMC 1993; Pneumologie 6-002-L-20, Cancerologie 60-6-250-A-10.
113. Mountain CF. Biologic, physiologic and technical determinants in surgical therapy for lung cáncer. En: Strauss MJ, editor. Lung cáncer. Clinical diagnosis and treatment (2.a ed.). Nueva York. Gruñe & Stratton, 1983; 245-260.
114. Mountain CF, Lukerman JM, Hammar SP et al. LCSG Pathology Committee. Lung cáncer classification: the relationship of disease extent and cell type to survival in a clinical triáis population. J Surg Oncol 1987; 35: 147-156.
115. Cantó A, Martorell M, Arnau A et al. Significado del cáncer broncopulmonar que se acompaña de un derrame pleural homolateral. Arch Bronconeumol 1991; 27: 254-258.
116. Cantó A. Derrame pleural asociado a cáncer de pulmón. Problemática de su clasificación según las categorías TNM. Arch Bronconeumol 1996;32:115-117.
117. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. J Thorac Cardiovasc Surg 1994; 107: 1.087-1.094.
118. 0 non-small cell lung cáncer. Ann Thorac Surg 1995; 60: 615-623.